Related Experiment Video
Updated: Jul 16, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Acute liver failure: liver support therapies
Vanessa Stadlbauer1, Rajiv Jalan
1Liver Failure Group, The Institute of Hepatology, Division of Medicine, University College London, London, UK.
Therapeutic strategies for acute liver failure, including bioartificial and artificial liver support, are reviewed. While these systems show promise in improving patient parameters, further development is needed to enhance survival rates.
Area of Science:
- Hepatology
- Biomedical Engineering
- Critical Care Medicine
Background:
- Acute liver failure (ALF) presents a high mortality rate, with liver transplantation being the primary but limited treatment.
- Understanding the complex pathophysiology of ALF is crucial for developing effective interventions.
- Extracorporeal liver support aims to bridge patients to recovery or transplantation.
Purpose of the Study:
- To summarize therapeutic approaches for acute liver failure, focusing on bioartificial and artificial liver support systems.
- To review recent advances in understanding ALF pathophysiology and their impact on treatment strategies.
- To evaluate the current status and future directions of extracorporeal liver support.
Main Methods:
- Review of current literature on acute liver failure treatments.
- Analysis of bioartificial liver support (BALS) systems utilizing hepatocytes.
- Evaluation of artificial liver support (ALS) systems for toxin removal.
Main Results:
- Both BALS and ALS systems can be safely applied and improve clinical and biochemical parameters in ALF patients.
- BALS devices have not yet demonstrated improved survival rates, but ongoing development is promising.
- ALS systems show potential in modulating ALF's pathophysiological mechanisms, though survival data remain limited.
Conclusions:
- Despite advances, mortality in acute liver failure remains high, necessitating alternative therapeutic options beyond transplantation.
- Further research into ALF pathophysiology and device engineering is essential for effective extracorporeal liver assist.
- Bioartificial and artificial liver support represent critical areas for future therapeutic development in ALF management.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Heart Failure VI: Adjunct Therapies
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...

